Avidity Biosciences, Inc. — Form D/A

Avidity Biosciences, Inc. of San Diego, CA, a company, filed a Form D amendment with the SEC on 2014-02-18. The offering totals $9.1M, of which $9.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Mark E DavisDirectorLa Jolla, CA
Frank E McCormickDirectorLa Jolla, CA
Troy WilsonExecutive OfficerSan Francisco, CA
Roderick WongDirectorNew York, NY
MICHAEL MARTINDirectorMinneapolis, MN
Troy WilsonDirectorSan Francisco, CA
Noreen Michael HenigDirectorSan Diego, CA
Carsten Michael BoessDirectorSan Diego, CA
Troy Michael WilsonDirectorSan Diego, CA
Tamar Michael ThompsonDirectorSan Diego, CA
Sarah BoyceDirectorSan Diego, CA
Sarah BoyceExecutive OfficerSan Diego, CA
Teresa Michael McCarthyExecutive OfficerSan Diego, CA
Edward Michael KayeDirectorSan Diego, CA
Jean Michael KimDirectorSan Diego, CA
W. Michael FlanaganExecutive OfficerSan Diego, CA
Arthur LevinExecutive OfficerSan Diego, CA
Michael Michael MacLeanExecutive OfficerSan Diego, CA
Todd BradyDirectorAtlanta, GA
EDWARD KAYEDirectorLA JOLLA, CA
NOREEN HENIGDirectorLA JOLLA, CA
P. Kent HawrylukExecutive OfficerCarmel, IN
Troy Wilson PhD., JDDirectorLa Jolla, CA
Troy Wilson PhD., JDExecutive OfficerLa Jolla, CA
Michael Martin PhD.DirectorLa Jolla, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2024-03-19D$400.2M$400.2M
2019-11-13D$103.8M$100.5M
2017-01-06D$23.3M$18.0M
2014-02-18D$9.1M$9.1M

More